Braun Stacey Associates Inc. Raises Position in UnitedHealth Group Incorporated (NYSE:UNH)

Braun Stacey Associates Inc. boosted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 6.0% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 45,941 shares of the healthcare conglomerate's stock after buying an additional 2,599 shares during the quarter. Braun Stacey Associates Inc.'s holdings in UnitedHealth Group were worth $26,861,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in the stock. Kathleen S. Wright Associates Inc. bought a new stake in UnitedHealth Group in the third quarter worth approximately $27,000. Macroview Investment Management LLC raised its holdings in UnitedHealth Group by 671.4% during the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate's stock worth $28,000 after buying an additional 47 shares during the last quarter. Bbjs Financial Advisors LLC purchased a new stake in shares of UnitedHealth Group in the second quarter worth approximately $31,000. Global Wealth Strategies & Associates boosted its position in shares of UnitedHealth Group by 152.4% during the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate's stock valued at $31,000 after buying an additional 32 shares during the last quarter. Finally, Signature Resources Capital Management LLC lifted its position in shares of UnitedHealth Group by 40.0% during the second quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate's stock valued at $32,000 after purchasing an additional 18 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.

Analyst Ratings Changes

Several analysts have commented on UNH shares. Morgan Stanley lowered their price objective on shares of UnitedHealth Group from $615.00 to $610.00 and set an "overweight" rating on the stock in a research report on Wednesday, October 16th. TD Cowen increased their price objective on UnitedHealth Group from $601.00 to $609.00 and gave the company a "buy" rating in a report on Friday, October 18th. Truist Financial reaffirmed a "buy" rating and set a $625.00 price target (down previously from $640.00) on shares of UnitedHealth Group in a research report on Wednesday, October 16th. Barclays lowered their price objective on UnitedHealth Group from $604.00 to $603.00 and set an "overweight" rating on the stock in a research note on Tuesday, October 22nd. Finally, StockNews.com raised shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a research report on Tuesday, November 12th. Three analysts have rated the stock with a hold rating, eighteen have issued a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, UnitedHealth Group currently has an average rating of "Moderate Buy" and an average price target of $615.53.

UnitedHealth Group Price Performance

Shares of UNH traded down $1.89 during midday trading on Monday, reaching $590.34. The stock had a trading volume of 1,434,417 shares, compared to its average volume of 3,877,572. The company's 50-day moving average is $582.84 and its 200 day moving average is $549.98. The company has a market capitalization of $543.28 billion, a price-to-earnings ratio of 38.29, a price-to-earnings-growth ratio of 1.74 and a beta of 0.58. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping analysts' consensus estimates of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business had revenue of $100.82 billion for the quarter, compared to analysts' expectations of $99.14 billion. During the same period in the previous year, the firm earned $6.56 EPS. The business's quarterly revenue was up 9.2% on a year-over-year basis. On average, equities analysts predict that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.42%. The ex-dividend date of this dividend is Monday, December 9th. UnitedHealth Group's payout ratio is 54.72%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.